Asia-Pacific Nations Seek Early Supply of Merck’s Home Covid Pill
Published
The countries are moving to buy molnupiravir, which the company says could halve the risk of virus hospitalization and death. Here’s the latest.
Full ArticlePublished
The countries are moving to buy molnupiravir, which the company says could halve the risk of virus hospitalization and death. Here’s the latest.
Full ArticleWatch VideoA cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for..
Watch VideoDrugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new..